Join the Nephropathy group to help and get support from people like you.
Nephropathy News
Calliditas Therapeutics Announces Full FDA Approval of Tarpeyo, the Only FDA-Approved Treatment for IgA Nephropathy to Significantly Reduce the Loss of Kidney Function
December 20, 2023 Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) (“Calliditas”), today announced that the U.S. Food and Drug Administration (FDA) has approved Tarpeyo (budesonide) ...
Budesonide Yields Durable Reduction in eGFR for IgA Nephropathy
MONDAY, Aug. 21, 2023 – For patients with immunoglobulin A (IgA) nephropathy, nine months of treatment with targeted-release formulation of budesonide (Nefecon) yields a greater reduction in...
FDA Approves Tarpeyo (budesonide) to Reduce Proteinuria in IgA Nephropathy
STOCKHOLM, Dec. 15, 2021 /PRNewswire/ – Calliditas Therapeutics AB (Nasdaq: CALT) (Nasdaq Stockholm: CALTX) ("Calliditas") today announced that the US Food and Drug Administration (FDA) has approved...
Ask a question
To post your own question to this support group, sign in or create an account.